MAPK3 and Parkinson disease: In order to validate our LID model, in this study we not only determined the AIM score but also examined protein and mRNA levels of c-Fos and ERK1/2 and found that they were reactivated in LID rats compared to PD rats, consistent with previous reports [36–40].